Non-small cell lung cancer: Clinical practice guidelines in oncology Journal Article


Authors: Ettinger, D. S.; Akerley, W.; Borghaei, H.; Chang, A. C.; Cheney, R. T.; Chirieac, L. R.; D'Amico, T. A.; Demmy, T. L.; Ganti, A. K. P.; Govindan, R.; Grannis, F. W. Jr; Horn, L.; Jahan, T. M.; Jahanzeb, M.; Kessinger, A.; Komaki, R.; Kong, F. M.; Kris, M. G.; Krug, L. M.; Lennes, I. T.; Loo, B. W. Jr; Martins, R.; O'Malley, J.; Osarogiagbon, R. U.; Otterson, G. A.; Patel, J. D.; Pinder-Schenck, M. C.; Pisters, K. M.; Reckamp, K.; Riely, G. J.; Rohren, E.; Swanson, S. J.; Wood, D. E.; Yang, S. C.; Hughes, M.; Gregory, K. M.
Article Title: Non-small cell lung cancer: Clinical practice guidelines in oncology
Abstract: Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion. © JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 10
Issue: 10
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2012-10-01
Start Page: 1236
End Page: 1271
Language: English
PROVIDER: scopus
PUBMED: 23054877
DOI/URL:
Notes: --- - "Export Date: 2 January 2013" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Lee M Krug
    178 Krug
  2. Gregory J Riely
    599 Riely
  3. Mark Kris
    869 Kris